Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4512)
All Articles published online
|
Jan 28, 2008 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou YM, Yin ZF, Yang JM, Li B, Shao WY, Xu F, Wang YL, Li DQ. Risk factors for intrahepatic cholangiocarcinoma: A case-control study in China. World J Gastroenterol 2008; 14(4): 632-635 [PMID: 18203300 DOI: 10.3748/wjg.14.632] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i4/632.htm |
| Number | Citing Articles |
| 1 |
Hai‐Rim Shin, Jin‐Kyoung Oh, Eric Masuyer, Maria‐Paula Curado, Veronique Bouvard, Yue‐Yi Fang, Surapon Wiangnon, Banchob Sripa, Sung‐Tae Hong. Epidemiology of cholangiocarcinoma: An update focusing on risk factors. Cancer Science 2010; 101(3): 579 doi: 10.1111/j.1349-7006.2009.01458.x
|
| 2 |
Alina Pascale, Olivier Rosmorduc, Jean-Charles Duclos-Vallée. New epidemiologic trends in cholangiocarcinoma. Clinics and Research in Hepatology and Gastroenterology 2023; 47(9): 102223 doi: 10.1016/j.clinre.2023.102223
|
| 3 |
Kyu Sik Jung, Kyeong Hyeon Chun, Gi Hong Choi, Hyae Min Jeon, Hye Sun Shin, Young Nyun Park, Jun Yong Park. Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports. BMC Research Notes 2013; 6(1) doi: 10.1186/1756-0500-6-520
|
| 4 |
Jeffrey S. Chang, Chia-Rung Tsai, Li-Tzong Chen, Fu-Sheng Wang. Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control Study. PLoS ONE 2013; 8(7): e69981 doi: 10.1371/journal.pone.0069981
|
| 5 |
Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco Negro, Christian Trépo. Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection. Clinical Gastroenterology and Hepatology 2010; 8(11): 924 doi: 10.1016/j.cgh.2010.06.032
|
| 6 |
Xiaofei Cheng, Feng Zhao, Dong Chen, Piao Yang, Weixiang Zhong, Xiangming Xu, Weilin Wang. Successful treatment of colorectal liver metastasis harboring intrahepatic cholangiocarcinoma. Medicine 2018; 97(51): e13751 doi: 10.1097/MD.0000000000013751
|
| 7 |
Meng Sha, Seogsong Jeong, Xin Wang, Ying Tong, Jie Cao, Han-Yong Sun, Lei Xia, Ning Xu, Zhi-Feng Xi, Jian-Jun Zhang, Xiao-Ni Kong, Qiang Xia. Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5420-z
|
| 8 |
Ping Wang, Yu He, Xiaodong Ma, Beiwang Sun, Binyuan Huang, Canhua Zhu, Yanmin Liu. Expression and Significance of COX-2 and Ki-67 in Hepatolithiasis with Bile Duct Carcinoma. Medical Science Monitor 2015; 21: 2943 doi: 10.12659/MSM.894330
|
| 9 |
Jessica L. Petrick, Jake E. Thistle, Anne Zeleniuch-Jacquotte, Xuehong Zhang, Jean Wactawski-Wende, Alison L. Van Dyke, Meir J. Stampfer, Rashmi Sinha, Howard D. Sesso, Catherine Schairer, Lynn Rosenberg, Thomas E. Rohan, Kim Robien, Mark P. Purdue, Jenny N. Poynter, Julie R. Palmer, Christina C. Newton, Martha S. Linet, Linda M. Liao, I-Min Lee, Jill Koshiol, Cari M. Kitahara, Jonathan N. Hofmann, Barry I. Graubard, Edward Giovannucci, Michael J. Gaziano, Susan M. Gapstur, Neal D. Freedman, Dawn Q. Chong, Andrew T. Chan, Julie E. Buring, Laura Beane E. Freeman, Peter T. Campbell, Katherine A. McGlynn. Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis. American Journal of Gastroenterology 2018; 113(10): 1494 doi: 10.1038/s41395-018-0207-4
|
| 10 |
Abigail Zabron, Robert J. Edwards, Shahid A. Khan. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Disease Models & Mechanisms 2013; 6(2): 281 doi: 10.1242/dmm.010561
|
| 11 |
Beihui Xue, Sunjie Wu, Mingyue Zhang, Junjie Hong, Bole Liu, Nina Xu, Qiqiang Zeng, Kun Tang, Xiangwu Zheng. A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasis. Abdominal Radiology 2021; 46(8): 3835 doi: 10.1007/s00261-021-03027-6
|
| 12 |
Miaoyan Wei, Lisheng Lü, Peiyi Lin, Zhisheng Chen, Zhiwei Quan, Zhaohui Tang. Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinoma. Cancer Letters 2016; 379(2): 253 doi: 10.1016/j.canlet.2016.02.038
|
| 13 |
Hao Zhang, Biqing Zhu, He Zhang, Jianxin Liang, Wenting Zeng. HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3417976
|
| 14 |
G. L. Tyson, S. Keihanian, H. B. El-Serag. Hilar Cholangiocarcinoma. 2013; : 17 doi: 10.1007/978-94-007-6473-6_2
|
| 15 |
T. Peter Kingham, Victoria G. Aveson, Alice C. Wei, Jason A. Castellanos, Peter J. Allen, Daniel P. Nussbaum, Yinin Hu, Michael I. D'Angelica. Surgical management of biliary malignancy. Current Problems in Surgery 2021; 58(2): 100854 doi: 10.1016/j.cpsurg.2020.100854
|
| 16 |
Linchao Ding, Shilong Ning, Weijian Hu, Yadong Xue, Shi’an Yu, Md Sayed Ali Sheikh. Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/6595989
|
| 17 |
Gary M Clifford. Expanding the list of cancers recognized to be caused by infectious agents. JNCI: Journal of the National Cancer Institute 2024; doi: 10.1093/jnci/djae185
|
| 18 |
Shao-Qiang Li, Li-Jian Liang, Yun-Peng Hua, Bao-Gang Peng, Dong Chen, Shun-Jun Fu. Bilateral liver resection for bilateral intrahepatic stones. World Journal of Gastroenterology 2009; 15(29): 3660-3663 doi: 10.3748/wjg.15.3660
|
| 19 |
Min Li, Jinzheng Li, Peizhi Li, Hongyang Li, Tianyi Su, Rongtao Zhu, Jianping Gong. Hepatitis B virus infection increases the risk of cholangiocarcinoma: A meta‐analysis and systematic review. Journal of Gastroenterology and Hepatology 2012; 27(10): 1561 doi: 10.1111/j.1440-1746.2012.07207.x
|
| 20 |
Yiqi Wu, Tianzhen Wang, Shengqian Ye, Ran Zhao, Xiaohui Bai, Yingying Wu, Kenji Abe, Xiaoming Jin. Detection of hepatitis B virus DNA in paraffin-embedded intrahepatic and extrahepatic cholangiocarcinoma tissue in the northern Chinese population. Human Pathology 2012; 43(1): 56 doi: 10.1016/j.humpath.2011.04.004
|
| 21 |
Ban Seok Lee, Eun-Cheol Park, Seung Woo Park, Chung Mo Nam, Jaehoon Roh. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: A case-control study in Korea. World Journal of Gastroenterology 2015; 21(2): 502-510 doi: 10.3748/wjg.v21.i2.502
|
| 22 |
Kun-Ming Chan, Chun-Yi Tsai, Chun-Nan Yeh, Ta-Sen Yeh, Wei-Chen Lee, Yi-Yin Jan, Miin-Fu Chen. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0912-x
|
| 23 |
Shun-ichi Ariizumi, Masakazu Yamamoto. Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis. Surgery Today 2015; 45(6): 682 doi: 10.1007/s00595-014-1031-0
|
| 24 |
Roongruedee Chaiteerakij, Ju Dong Yang, William S. Harmsen, Seth W. Slettedahl, Teresa A. Mettler, Zachary S. Fredericksen, Ray W. Kim, Gregory J. Gores, Rosebud O. Roberts, Janet E. Olson, Terry M. Therneau, Lewis R. Roberts. Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk. Hepatology 2013; 57(2): 648 doi: 10.1002/hep.26092
|
| 25 |
Alan W. Hemming. Biliary Tract and Primary Liver Tumors. Surgical Oncology Clinics of North America 2019; 28(4): 519 doi: 10.1016/j.soc.2019.06.012
|
| 26 |
Allyson K. Martínez, Kendal Jensen, Chad Hall, April O'Brien, Laurent Ehrlich, Tori White, Fanyin Meng, Tianhao Zhou, John Greene, Francesca Bernuzzi, Pietro Invernizzi, David E. Dostal, Terry Lairmore, Gianfranco Alpini, Shannon S. Glaser. Nicotine Promotes Cholangiocarcinoma Growth in Xenograft Mice. The American Journal of Pathology 2017; 187(5): 1093 doi: 10.1016/j.ajpath.2017.01.011
|
| 27 |
S. Ralphs, S. A. Khan. The role of the hepatitis viruses in cholangiocarcinoma. Journal of Viral Hepatitis 2013; 20(5): 297 doi: 10.1111/jvh.12093
|
| 28 |
In Rae Cho, Sang-Wook Yi, Ja Sung Choi, Jee-Jeon Yi. Comparison of Risk Factors for Cholangiocarcinoma and Hepatocellular Carcinoma: A Prospective Cohort Study in Korean Adults. Cancers 2022; 14(7): 1709 doi: 10.3390/cancers14071709
|
| 29 |
Jessica L. Petrick, Andrea A. Florio, Rohit Loomba, Katherine A. McGlynn. Have incidence rates of liver cancer peaked in the United States?. Cancer 2020; 126(13): 3151 doi: 10.1002/cncr.32794
|
| 30 |
学河 朱. Typing, Risk Factors and Related Treatments of Cholangiocarcinoma. Advances in Clinical Medicine 2014; 4(04): 74 doi: 10.12677/ACM.2014.44014
|
| 31 |
C. de Martel, M. Plummer, S. Franceschi. Cholangiocarcinoma: Descriptive epidemiology and risk factors. Gastroentérologie Clinique et Biologique 2010; 34(3): 173 doi: 10.1016/j.gcb.2010.01.008
|
| 32 |
Felice Giuliante, Agostino Maria De Rose, Gennaro Nuzzo. Benign Tumors of the Liver. 2015; : 129 doi: 10.1007/978-3-319-12985-3_10
|
| 33 |
Beihui Xue, Sunjie Wu, Minghua Zheng, Huanchang Jiang, Jun Chen, Zhenghao Jiang, Tian Tian, Yifan Tu, Huanhu Zhao, Xian Shen, Kuvaneshan Ramen, Xiuling Wu, Qiyu Zhang, Qiqiang Zeng, Xiangwu Zheng. Development and Validation of a Radiomic-Based Model for Prediction of Intrahepatic Cholangiocarcinoma in Patients With Intrahepatic Lithiasis Complicated by Imagologically Diagnosed Mass. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.598253
|
| 34 |
Ben-Dong Chen, Wen-Chao Zhao, Jian-Da Dong, Hui Sima. Expression of GLP-1R protein and its clinical role in intrahepatic cholangiocarcinoma tissues. Molecular Biology Reports 2014; 41(7): 4313 doi: 10.1007/s11033-014-3302-7
|
| 35 |
Ruben R. Plentz, Nisar P. Malek. Clinical presentation, risk factors and staging systems of cholangiocarcinoma. Best Practice & Research Clinical Gastroenterology 2015; 29(2): 245 doi: 10.1016/j.bpg.2015.02.001
|
| 36 |
Nanna M. Uldall Torp, Simon B. Kristensen, Frank V. Mortensen, Jakob Kirkegård. Cholecystitis and risk of pancreatic, liver, and biliary tract cancer in patients undergoing cholecystectomy. HPB 2020; 22(9): 1258 doi: 10.1016/j.hpb.2019.11.012
|
| 37 |
Shinichi Aishima, Tomohiro Iguchi, Nobuhiro Fujita, Akinobu Taketomi, Yoshihiko Maehara, Masazumi Tsuneyoshi, Yoshinao Oda. Histological and immunohistological findings in biliary intraepithelial neoplasia arising from a background of chronic biliary disease compared with liver cirrhosis of non‐biliary aetiology. Histopathology 2011; 59(5): 867 doi: 10.1111/j.1365-2559.2011.04011.x
|
| 38 |
Yanming Zhou, Yanfang Zhao, Bin Li, Jiyi Huang, Lupeng Wu, Donghui Xu, Jiamei Yang, Jia He. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-289
|
| 39 |
Hao Li, Bin Hu, Zun-Qiang Zhou, Jiao Guan, Zheng-Yun Zhang, Guang-Wen Zhou. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies. World Journal of Surgical Oncology 2015; 13(1) doi: 10.1186/s12957-015-0583-9
|
| 40 |
Rachel M. Lee, Shishir K. Maithel. Approaches and Outcomes to Distal Cholangiocarcinoma. Surgical Oncology Clinics of North America 2019; 28(4): 631 doi: 10.1016/j.soc.2019.06.014
|
| 41 |
Lian-Yuan Tao, Xiao-Dong He, Qiang Qu, Lei Cai, Wei Liu, Li Zhou, Shang-Ming Zhang. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a caseâcontrol study in China. Liver International 2010; 30(2): 215 doi: 10.1111/j.1478-3231.2009.02149.x
|
| 42 |
Roongruedee Chaiteerakij, Wirichada Pan-ngum, Kittiyod Poovorawan, Ngamphol Soonthornworasiri, Sombat Treeprasertsuk, Kamthorn Phaosawasdi. Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study. World Journal of Gastroenterology 2017; 23(39): 7160-7167 doi: 10.3748/wjg.v23.i39.7160
|
| 43 |
Andrea A. Florio, Jacques Ferlay, Ariana Znaor, David Ruggieri, Christian S. Alvarez, Mathieu Laversanne, Freddie Bray, Katherine A. McGlynn, Jessica L. Petrick. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer 2020; 126(11): 2666 doi: 10.1002/cncr.32803
|
| 44 |
Shao-Liang Han, Hong-Zhong Zhou, Jun Cheng, Sheng-Hong Lan, Pei-Chen Zhang, Zhe-Jing Chen, Qi-Qiang Zeng. Diagnosis and Surgical Treatment of Intrahepatic Hepatolithiasis Associated Cholangiocarcinoma. Asian Journal of Surgery 2009; 32(1): 1 doi: 10.1016/S1015-9584(09)60001-4
|
| 45 |
Hong-Yang Li, Shi-Ji Zhou, Min Li, Ding Xiong, Akanand Singh, Qing-Xi Guo, Chang-An Liu, Jian-Ping Gong. Diagnosis and Cure Experience of Hepatolithiasis-Associated Intrahepatic Cholangiocarcinoma in 66 Patients. Asian Pacific Journal of Cancer Prevention 2012; 13(2): 725 doi: 10.7314/APJCP.2012.13.2.725
|
| 46 |
Oliver Clements, Joseph Eliahoo, Jin Un Kim, Simon D. Taylor-Robinson, Shahid A. Khan. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Journal of Hepatology 2020; 72(1): 95 doi: 10.1016/j.jhep.2019.09.007
|
| 47 |
Tushar Patel. New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma. Journal of Gastroenterology 2014; 49(2): 165 doi: 10.1007/s00535-013-0894-y
|
| 48 |
Chyng-Wen Fwu, Yin-Chu Chien, San-Lin You, Kenrad E. Nelson, Gregory D. Kirk, Hsu-Sung Kuo, Manning Feinleib, Chien-Jen Chen. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in Taiwan. Hepatology 2011; 53(4): 1217 doi: 10.1002/hep.24150
|
| 49 |
Samuel O. Antwi, Omar Y. Mousa, Tushar Patel. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014. Annals of Hepatology 2018; 17(4): 604 doi: 10.5604/01.3001.0012.0929
|
| 50 |
Jun Yan, Tatsuo Kanda, Shuang Wu, Fumio Imazeki, Osamu Yokosuka. Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan. Hepatology Research 2012; 42(10): 974 doi: 10.1111/j.1872-034X.2012.01009.x
|
| 51 |
Yan Zhang, Zhuo Ying Li, Qiu Ming Shen, Jia Yi Tuo, Jing Yu Tan, Yu Ting Tan, Hong Lan Li, Yong Bing Xiang. A prospective cohort study of cigarette smoking, alcohol drinking and liver cancer incidence in Chinese men. Journal of Digestive Diseases 2022; 23(8-9): 527 doi: 10.1111/1751-2980.13136
|
| 52 |
Ya-yong Li, Hao Li, Pin Lv, Gang Liu, Xiao-rong Li, Bu-ning Tian, Dao-jin Chen. Prognostic Value of Cirrhosis for Intrahepatic Cholangiocarcinoma After Surgical Treatment. Journal of Gastrointestinal Surgery 2011; 15(4): 608 doi: 10.1007/s11605-011-1419-8
|
| 53 |
W. F. Shen, W. Zhong, Q. Liu, C. J. Sui, Y. Q. Huang, J. M. Yang. Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control Study. World Journal of Surgery 2011; 35(9): 2083 doi: 10.1007/s00268-011-1171-y
|
| 54 |
M. Tanaka, H. Tanaka, H. Tsukuma, A. Ioka, A. Oshima, T. Nakahara. Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus. Journal of Viral Hepatitis 2010; 17(10): 742 doi: 10.1111/j.1365-2893.2009.01243.x
|
| 55 |
Dietmar Tamandl, Beata Herberger, Birgit Gruenberger, Harald Puhalla, Markus Klinger, Thomas Gruenberger. Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology 2008; 15(10): 2787 doi: 10.1245/s10434-008-0081-1
|
| 56 |
Qiao Wu, Xiao-Dong He, Lan Yu, Wei Liu, Lian-Yuan Tao. The Metabolic Syndrome and Risk Factors for Biliary Tract Cancer: A Case-control Study in China. Asian Pacific Journal of Cancer Prevention 2012; 13(5): 1963 doi: 10.7314/APJCP.2012.13.5.1963
|
| 57 |
海玲 乔. Progress in Treatment of Unresectable Intrahepatic Cholangiocarcinoma. Advances in Clinical Medicine 2023; 13(12): 19815 doi: 10.12677/ACM.2023.13122790
|
| 58 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 605 doi: 10.1007/978-3-319-26956-6_31
|
| 59 |
Chia-Sheng Chu, Che-Chen Lin, Cheng-Yuan Peng, Po-Heng Chuang, Wen-Pang Su, Shih-Wei Lai, Hsuan-Ju Chen, Chi-Jung Chung, Hsueh-Chou Lai. Does pyogenic liver abscess increase the risk of delayed-onset primary liver cancer?. Medicine 2017; 96(34): e7785 doi: 10.1097/MD.0000000000007785
|
| 60 |
Yan-Jiun Huang, Alexander TH Wu, Hung-Yi Chiou, Ming-Tsang Chuang, Tzu-Ching Meng, Li-Nien Chien, Yun Yen. Interactive role of diabetes mellitus and female sex in the risk of cholangiocarcinoma: A population-based nested case-control study. Oncotarget 2017; 8(4): 6642 doi: 10.18632/oncotarget.14254
|
| 61 |
Stefania De Lorenzo, Francesco Tovoli, Alessandro Mazzotta, Francesco Vasuri, Julien Edeline, Deborah Malvi, Karim Boudjema, Matteo Renzulli, Heithem Jeddou, Antonietta D’Errico, Bruno Turlin, Matteo Cescon, Thomas Uguen, Alessandro Granito, Astrid Lièvre, Giovanni Brandi. Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role. Cancers 2020; 12(11): 3182 doi: 10.3390/cancers12113182
|
| 62 |
Yasuhiro Ito, Takeshi Kenmochi, Tomohisa Egawa, Shinobu Hayashi, Atsushi Nagashima, Yuko Kitagawa. Diagnosis of Distal Cholangiocarcinoma after the Removal of Choledocholithiasis. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/396869
|
| 63 |
Chiara Braconi, Tushar Patel. Cholangiocarcinoma: New Insights into Disease Pathogenesis and Biology. Infectious Disease Clinics of North America 2010; 24(4): 871 doi: 10.1016/j.idc.2010.07.006
|
| 64 |
L. Zender, N. P. Malek. Diagnostik und Therapie des cholangiozellulären Karzinoms. Der Internist 2016; 57(12): 1191 doi: 10.1007/s00108-016-0128-5
|
| 65 |
Riham Katkhuda, Yun Shin Chun. Intrahepatic Cholangiocarcinoma. 2019; : 1 doi: 10.1007/978-3-030-22258-1_1
|
| 66 |
Li Jiang, Li-Sheng Jiang, Lu-Nan Yan, Fu-Yu Li, Wei Wang, Nan-Sheng Cheng, Tian-Fu Wen. Effects of Epidermal Growth Factor Receptor Inhibitor Genistein on Proliferative Cholangitis in Rats. Journal of Surgical Research 2010; 162(1): 59 doi: 10.1016/j.jss.2009.04.048
|
| 67 |
Jun-hua LU, Jing ZHANG, Guang-shun YANG, Jun ZHAO, Ning YANG, Hai-bin ZHANG, Chun-feng SHI, Tian YANG. Diagnosis and treatment of long-term hepatolithiasis associated with intrahepatic cholangiocarcinoma. Academic Journal of Second Military Medical University 2009; 28(9): 1128 doi: 10.3724/SP.J.1008.2008.01128
|
| 68 |
William C. Palmer, Tushar Patel. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. Journal of Hepatology 2012; 57(1): 69 doi: 10.1016/j.jhep.2012.02.022
|
| 69 |
Ming‐Shian Tsai, Po‐Huang Lee, Cheng‐Li Lin, Chiao‐Ling Peng, Chia‐Hung Kao. Type II diabetes mellitus is associated with a reduced risk of cholangiocarcinoma in patients with biliary tract diseases. International Journal of Cancer 2015; 136(10): 2409 doi: 10.1002/ijc.29292
|
| 70 |
Sirio Fiorino, Letizia Bacchi-Reggiani, Dario de Biase, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Giorgia Acquaviva, Luca di Tommaso, Arrigo Bondi, Michela Visani, Sergio Sabbatani, Laura Pontoriero, Carlo Fabbri, Andrea Cuppini, Annalisa Pession, Elio Jovine. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. World Journal of Gastroenterology 2015; 21(45): 12896-12953 doi: 10.3748/wjg.v21.i45.12896
|
| 71 |
Seogsong Jeong, Ying Tong, Meng Sha, Jinyang Gu, Qiang Xia. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncotarget 2017; 8(10): 17292 doi: 10.18632/oncotarget.14079
|
| 72 |
Yong Eun Chung, Myeong-Jin Kim, Young Nyun Park, Jin-Young Choi, Ju Yeon Pyo, Young Chul Kim, Hyeon Je Cho, Kyung Ah Kim, Sun Young Choi. Varying Appearances of Cholangiocarcinoma: Radiologic-Pathologic Correlation. RadioGraphics 2009; 29(3): 683 doi: 10.1148/rg.293085729
|
| 73 |
Yoshito Ikematsu, Tsutomu Tomioka, Tsukasa Tsunoda, Yoshitsugu Tajima, Takashi Kanematsu. Hepatobiliary and Pancreatic Carcinogenesis in the Hamster. 2009; : 115 doi: 10.1007/978-4-431-87773-8_9
|
| 74 |
Murad Aljiffry, Mark J Walsh, Michele Molinari. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World Journal of Gastroenterology 2009; 15(34): 4240-4262 doi: 10.3748/wjg.15.4240
|
| 75 |
Nikolaos Fragkou, Lazaros Sideras, Panteleimon Panas, Christos Emmanouilides, Emmanouil Sinakos. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?. World Journal of Gastroenterology 2021; 27(27): 4252-4275 doi: 10.3748/wjg.v27.i27.4252
|
| 76 |
Yan-Ming Zhou, Lu Cao, Bin Li, Xiu-Zhong Zhang, Zheng-Feng Yin. Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma. Hepatobiliary & Pancreatic Diseases International 2012; 11(5): 532 doi: 10.1016/S1499-3872(12)60219-7
|
| 77 |
Men-Bao Qian, Ying-Dan Chen, Song Liang, Guo-Jing Yang, Xiao-Nong Zhou. The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma. Infectious Diseases of Poverty 2012; 1(1) doi: 10.1186/2049-9957-1-4
|
| 78 |
A. Shin, S. Park, H.R. Shin, E.-H. Park, S.K. Park, J.-K. Oh, M.-K. Lim, B.Y. Choi, M. Boniol, P. Boffetta. Population attributable fraction of infection-related cancers in Korea. Annals of Oncology 2011; 22(6): 1435 doi: 10.1093/annonc/mdq592
|
| 79 |
Lingyu Tian, Jiaqiang Ma, Lijie Ma, Bohao Zheng, Longzi Liu, Danjun Song, Yining Wang, Zhao Zhang, Qiang Gao, Kang Song, Xiaoying Wang. PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-02082-5
|
| 80 |
Neil Bhardwaj, David M. Lloyd. Handbook of Gastrointestinal Cancer. 2012; : 182 doi: 10.1002/9781118423318.ch8
|
| 81 |
Yuenan Huang, Liuping You, Weimin Xie, Li Ning, Jinghe Lang. Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis. Oncotarget 2017; 8(59): 100570 doi: 10.18632/oncotarget.20141
|
| 82 |
Aaron P. Thrift, Hashem B. El-Serag, Fasiha Kanwal. Global epidemiology and burden of HCV infection and HCV-related disease. Nature Reviews Gastroenterology & Hepatology 2017; 14(2): 122 doi: 10.1038/nrgastro.2016.176
|
| 83 |
Tarun Rustagi, Constantin A. Dasanu. Risk Factors for Gallbladder Cancer and Cholangiocarcinoma: Similarities, Differences and Updates. Journal of Gastrointestinal Cancer 2012; 43(2): 137 doi: 10.1007/s12029-011-9284-y
|
| 84 |
P W Ewald. 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Symbionts and immunopathology in chronic diseases: insights from evolution. Clinical and Experimental Immunology 2010; 160(1): 27 doi: 10.1111/j.1365-2249.2010.04127.x
|
| 85 |
Philipp Heumann, Andreas Albert, Karsten Gülow, Denis Tümen, Martina Müller, Arne Kandulski. Current and Future Therapeutic Targets for Directed Molecular Therapies in Cholangiocarcinoma. Cancers 2024; 16(9): 1690 doi: 10.3390/cancers16091690
|
| 86 |
Yan-Ming Zhou, Jia-Mei Yang, Bin Li, Zheng-Feng Yin, Feng Xu, Bin Wang, Peng Liu, Zhi-Min Li. Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein. World Journal of Gastroenterology 2008; 14(14): 2251-2254 doi: 10.3748/wjg.14.2251
|
| 87 |
Shinichi Aishima, Yuki Tanaka, Yuichiro Kubo, Ken Shirabe, Yoshihiko Maehara, Yoshinao Oda. Bile duct adenoma and von Meyenburg complex‐like duct arising in hepatitis and cirrhosis: Pathogenesis and histological characteristics. Pathology International 2014; 64(11): 551 doi: 10.1111/pin.12209
|
| 88 |
Gia L. Tyson, Hashem B. El-Serag. Risk factors for cholangiocarcinoma. Hepatology 2011; 54(1): 173 doi: 10.1002/hep.24351
|
| 89 |
Giuliana Cavalloni, Caterina Peraldo-Neia, Francesco Sassi, Giovanna Chiorino, Ivana Sarotto, Massimo Aglietta, Francesco Leone. Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2136-1
|
| 90 |
Rakesh Sahu, Praveen Sharma, Ajay Kumar. An Insight into Cholangiocarcinoma and Recent Advances in its Treatment. Journal of Gastrointestinal Cancer 2023; 54(1): 213 doi: 10.1007/s12029-021-00728-5
|
| 91 |
Mengge Li, Min Du, Hui Cong, Yuanyuan Gu, Yuan Fang, Jin Li, Yu Gan, Hong Tu, Jinyang Gu, Qiang Xia. Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma. Hepatology Research 2021; 51(1): 102 doi: 10.1111/hepr.13580
|
| 92 |
John Bridgewater, Peter R. Galle, Shahid A. Khan, Josep M. Llovet, Joong-Won Park, Tushar Patel, Timothy M. Pawlik, Gregory J. Gores. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. Journal of Hepatology 2014; 60(6): 1268 doi: 10.1016/j.jhep.2014.01.021
|
| 93 |
Hao Liang, Jianbing Wang, Huijuan Xiao, Ding Wang, Wenqiang Wei, Youlin Qiao, Paolo Boffetta. Estimation of cancer incidence and mortality attributable to alcohol drinking in china. BMC Public Health 2010; 10(1) doi: 10.1186/1471-2458-10-730
|
| 94 |
Wei-Feng Shen, Wei Zhong, Feng Xu, Tong Kan, Li Geng, Feng Xie, Cheng-Jun Sui, Jia-Mei Yang. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World Journal of Gastroenterology 2009; 15(47): 5976-5982 doi: 10.3748/wjg.15.5976
|
| 95 |
Maria-Cristina Navas, Shannon Glaser, Harshil Dhruv, Scott Celinski, Gianfranco Alpini, Fanyin Meng. Hepatitis C Virus Infection and Cholangiocarcinoma. The American Journal of Pathology 2019; 189(6): 1122 doi: 10.1016/j.ajpath.2019.01.018
|
| 96 |
Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: Update and future perspectives. Digestive and Liver Disease 2010; 42(4): 253 doi: 10.1016/j.dld.2009.12.008
|
| 97 |
Zhen-Yu Liu, Yan-Ming Zhou, Le-Hua Shi, Zheng-Feng Yin. Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study. Hepatobiliary & Pancreatic Diseases International 2011; 10(6): 626 doi: 10.1016/S1499-3872(11)60106-9
|
| 98 |
Zhi-Yuan Mao, Guang-Qing Zhu, Mei Xiong, Li Ren, Li Bai. Prognostic value of neutrophil distribution in cholangiocarcinoma. World Journal of Gastroenterology 2015; 21(16): 4961-4968 doi: 10.3748/wjg.v21.i16.4961
|
| 99 |
Sang Hoon Lee, Seung Woo Park. Inflammation and Cancer Development in Pancreatic and Biliary Tract Cancer. The Korean Journal of Gastroenterology 2015; 66(6): 325 doi: 10.4166/kjg.2015.66.6.325
|
| 100 |
Yufei Zhu, Yunhai Zhu, Feng Cai, Jie Zhao, Feng Liu. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma. Cell Biochemistry and Biophysics 2015; 73(2): 455 doi: 10.1007/s12013-015-0665-x
|
| 101 |
Shinichi Aishima, Nobuhiro Fujita, Yohei Mano, Tomohiro Iguchi, Akinobu Taketomi, Yoshihiko Maehara, Yoshinao Oda, Masazumi Tsuneyoshi. p62+ Hyaline Inclusions in Intrahepatic Cholangiocarcinoma Associated With Viral Hepatitis or Alcoholic Liver Disease. American Journal of Clinical Pathology 2010; 134(3): 457 doi: 10.1309/AJCP53YVVJCNDZIR
|
| 102 |
Ankitha Sivanand, Durva Talati, Yash Kalariya, Priyansh Patel, Siddharth Kamal Gandhi. Associations of Liver Fluke Infection and Cholangiocarcinoma: A Scoping Review. Cureus 2023; doi: 10.7759/cureus.46400
|
| 103 |
Paul W. Ewald. Natural History of Host-Parasite Interactions. Advances in Parasitology 2009; 68: 21 doi: 10.1016/S0065-308X(08)00602-7
|
| 104 |
C H Lee, C J Chang, Y J Lin, C N Yeh, M F Chen, S Y Hsieh. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. British Journal of Cancer 2009; 100(11): 1765 doi: 10.1038/sj.bjc.6605063
|
| 105 |
Samuel O. Antwi, Omar Y. Mousa, Tushar Patel. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014. Annals of Hepatology 2018; 17(2): 274 doi: 10.5604/01.3001.0010.8659
|
| 106 |
Di Sun, Min Ding, Mengfan Ruan, Li Yang, Xingshun Qi. Hepatitis C - Recent Advances. 2023; doi: 10.5772/intechopen.1001335
|
| 107 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_31-1
|
| 108 |
Hogil Kim, Yun Kyung Chung, Inah Kim. Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in Korea. Annals of Occupational and Environmental Medicine 2018; 30(1) doi: 10.1186/s40557-018-0217-0
|
| 109 |
Lei Zhang, Jian‐Qiang Cai, Jian‐Jun Zhao, Xin‐Yu Bi, Xiao‐Gang Tan, Tao Yan, Cong Li, Ping Zhao. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology 2010; 101(3): 233 doi: 10.1002/jso.21488
|
| 110 |
Masakazu Yamamoto, Shun-ichi Ariizumi. Surgical outcomes of intrahepatic cholangiocarcinoma. Surgery Today 2011; 41(7): 896 doi: 10.1007/s00595-011-4517-z
|
| 111 |
Paul W. Ewald, Holly A. Swain Ewald. . Advances in Parasitology 2014; 84: 1 doi: 10.1016/B978-0-12-800099-1.00001-6
|
| 112 |
Sergio Hoyos, Maria-Cristina Navas, Juan-Carlos Restrepo, Rafael Claudino Botero. Current controversies in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1461 doi: 10.1016/j.bbadis.2017.07.027
|
| 113 |
D Tamandl, K Kaczirek, B Gruenberger, C Koelblinger, J Maresch, R Jakesz, T Gruenberger. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. British Journal of Surgery 2009; 96(8): 919 doi: 10.1002/bjs.6654
|
| 114 |
Dong Kuang, Guo-Ping Wang. Hilar cholangiocarcinoma: Pathology and tumor biology. Frontiers of Medicine in China 2010; 4(4): 371 doi: 10.1007/s11684-010-0130-6
|
| 115 |
Nataliya Razumilava, Gregory J Gores. Cholangiocarcinoma. The Lancet 2014; 383(9935): 2168 doi: 10.1016/S0140-6736(13)61903-0
|